ES2092685T3 - Uso de atipamezol para el tratamiento de impotencia sexual masculina. - Google Patents

Uso de atipamezol para el tratamiento de impotencia sexual masculina.

Info

Publication number
ES2092685T3
ES2092685T3 ES92911915T ES92911915T ES2092685T3 ES 2092685 T3 ES2092685 T3 ES 2092685T3 ES 92911915 T ES92911915 T ES 92911915T ES 92911915 T ES92911915 T ES 92911915T ES 2092685 T3 ES2092685 T3 ES 2092685T3
Authority
ES
Spain
Prior art keywords
treatment
atipamezol
male sexual
sexual impotence
impotence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92911915T
Other languages
English (en)
Inventor
Antti Pertovaara
Ilkka Linnankoski
Raimo Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of ES2092685T3 publication Critical patent/ES2092685T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE LA ATIPAMEZOLA A UNA SAL DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE DE LA MISMA PARA EL TRATAMIENTO DE LA IMPOTENCIA SEXUAL MASCULINA.
ES92911915T 1991-06-18 1992-06-18 Uso de atipamezol para el tratamiento de impotencia sexual masculina. Expired - Lifetime ES2092685T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113077A GB9113077D0 (en) 1991-06-18 1991-06-18 Use of atipamezole

Publications (1)

Publication Number Publication Date
ES2092685T3 true ES2092685T3 (es) 1996-12-01

Family

ID=10696833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92911915T Expired - Lifetime ES2092685T3 (es) 1991-06-18 1992-06-18 Uso de atipamezol para el tratamiento de impotencia sexual masculina.

Country Status (21)

Country Link
EP (1) EP0589957B1 (es)
JP (1) JP3151217B2 (es)
KR (1) KR100324447B1 (es)
AT (1) ATE144141T1 (es)
AU (1) AU661698B2 (es)
CA (1) CA2102187C (es)
CZ (1) CZ284409B6 (es)
DE (1) DE69214647T2 (es)
DK (1) DK0589957T3 (es)
ES (1) ES2092685T3 (es)
GB (1) GB9113077D0 (es)
GR (1) GR3021677T3 (es)
HU (1) HU220068B (es)
IE (1) IE921735A1 (es)
IL (1) IL101961A (es)
MX (1) MX9202948A (es)
NO (1) NO304011B1 (es)
NZ (1) NZ242863A (es)
RU (1) RU2111749C1 (es)
WO (1) WO1992022296A1 (es)
ZA (1) ZA923961B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä

Also Published As

Publication number Publication date
CA2102187A1 (en) 1992-12-19
HU220068B (hu) 2001-10-28
EP0589957A1 (en) 1994-04-06
NO934690L (no) 1993-12-17
HUT65817A (en) 1994-07-28
ZA923961B (en) 1993-02-24
IE921735A1 (en) 1992-12-30
DE69214647T2 (de) 1997-02-20
AU1972492A (en) 1993-01-12
CZ284409B6 (cs) 1998-11-11
MX9202948A (es) 1993-04-01
NZ242863A (en) 1997-06-24
KR100324447B1 (ko) 2002-06-20
CZ248793A3 (en) 1994-04-13
AU661698B2 (en) 1995-08-03
EP0589957B1 (en) 1996-10-16
NO934690D0 (no) 1993-12-17
JPH06508350A (ja) 1994-09-22
GR3021677T3 (en) 1997-02-28
ATE144141T1 (de) 1996-11-15
IL101961A (en) 1995-12-31
NO304011B1 (no) 1998-10-12
CA2102187C (en) 2003-03-11
GB9113077D0 (en) 1991-08-07
IL101961A0 (en) 1992-12-30
DK0589957T3 (da) 1996-11-18
DE69214647D1 (de) 1996-11-21
RU2111749C1 (ru) 1998-05-27
WO1992022296A1 (en) 1992-12-23
JP3151217B2 (ja) 2001-04-03

Similar Documents

Publication Publication Date Title
CY1106239T1 (el) ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΔΙΑΜΟΡΦΩΣΕΙΣ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΕΛΕΥΘΕΡΩΣΗΣ ΠΟΥ ΠEPΙΕΧΟΥΝ ΑΝΑΣΤΟΛΕΑ cGMP PDE-5
DK1014966T3 (da) Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
DE69433784D1 (de) 9-(Substituiertes Glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxytetracycline
ES2069843T3 (es) Utilizacion de baclofen para la obtencion de medicamentos destinados al tratamiento de la angina de pecho.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
ES520914A0 (es) Procedimiento para el tratamiento de lodos industriales residuales.
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
ES2092685T3 (es) Uso de atipamezol para el tratamiento de impotencia sexual masculina.
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
ES2089194T3 (es) Nuevo uso de linomide.
ES1034986Y (es) Aparato para el tratamiento del cuerpo humano.
AR011178A1 (es) Compuesto de sal de sodio de (acido (e) 4,6-dicloro-3-(2-oxo-1- fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico en su forma hidratada,proceso para su preparacion, composicion farmaceutica que lo contiene y metodo de tratamiento utilizando dicho compuesto
MX9204286A (es) Agentes para el tratamiento de semillas.
ES2021753B3 (es) Dispositivo para el tensado de genero de punto tejido de forma tubular.
RU93058537A (ru) Применение атипамезола для лечения мужской сексуальной импотенции
ES2158647T3 (es) Uso de olanzapina para la fabricacion de un medicamento para el tratamiento de la isquemia cerebral focal.
ES1031636Y (es) Aparato para el aprovechamiento de aguas domesticas utilizadas.
ES1011920Y (es) Dispositivo para el tratamiento de los genitales masculinos.
ES1030216Y (es) Cinturon terapeutico para el tratamiento de la impotencia.
ES1009822Y (es) Dispositivo para el tratamiento de la impotencia sexual de hombres.
PT967986E (pt) Utilizacao de glicoproteina alfa1-acida para a preparacao de um preparado farmaceutico
ES1014887Y (es) Dispositivo para el control de la incontinencia masculina.
ES1004491Y (es) Horma para el tratamiento ortopedico de calzado.
ES1017890Y (es) Dispositivo para el tratamiento de uneros.
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 589957

Country of ref document: ES